Definium Therapeutics (DFTX) Change in Account Payables (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly Change in Account Payables of $1.8 million for Q1 2026, up 589.92% year-over-year from $258000.0 in Q1 2025, and up 164.35% quarter-over-quarter from -$2.8 million in Q4 2025.
Powered by 
Analysis
Definium Therapeutics (DFTX) Change in Account Payables (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Change in Account Payables for 6 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 589.92% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $4.9 million (up 243.89% YoY), while the FY2025 annual figure was $3.3 million, up 256.96% from the prior year.
- Change in Account Payables rose to $1.8 million in Q1 2026 per DFTX's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.3 million in Q2 2023 and bottomed at -$3.5 million in Q4 2023.
- Historically, Change in Account Payables has averaged $174117.6 across 5 years, with a median of $100000.0 in 2022.
- On a YoY basis, Change in Account Payables climbed as much as 829.78% in 2025 and fell as far as 1889.93% in 2025.
- Definium Therapeutics' Change in Account Payables stood at $1.3 million in 2022, then tumbled by 375.73% to -$3.5 million in 2023, then surged by 96.04% to -$139000.0 in 2024, then tumbled by 1889.93% to -$2.8 million in 2025, then soared by 164.35% to $1.8 million in 2026.
- Business Quant data shows DFTX's Change in Account Payables at $1.8 million in Q1 2026, -$2.8 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Definium Therapeutics | 4.23 Bn | 4.23 Bn | - | -162,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -162,000.00 |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | -2.77 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 258,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Sep 30, 2024 | -534,000.00 |
| Jun 30, 2024 | -2.96 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -3.51 Mn |
| Sep 30, 2023 | -931,000.00 |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 209,000.00 |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | -2.59 Mn |
| Mar 31, 2022 | -843,000.00 |
| Dec 31, 2021 | 648,000.00 |
| Sep 30, 2021 | 685,000.00 |